Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03195699 |
| Title | Phase I Study of Oral STAT3 Inhibitor, C188-9, in Patients With Advanced Cancers |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | StemMed, Ltd., USA |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| Mays Cancer Center at University of Texas Health Science Center SA | San Antonio | Texas | 78229 | United States | Details |